NO991548L - Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer - Google Patents
Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismerInfo
- Publication number
- NO991548L NO991548L NO991548A NO991548A NO991548L NO 991548 L NO991548 L NO 991548L NO 991548 A NO991548 A NO 991548A NO 991548 A NO991548 A NO 991548A NO 991548 L NO991548 L NO 991548L
- Authority
- NO
- Norway
- Prior art keywords
- mupirocin
- nasopharynx
- colonization
- drug
- manufacture
- Prior art date
Links
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003128 mupirocin Drugs 0.000 title abstract 2
- 229930187697 mupirocin Natural products 0.000 title abstract 2
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title abstract 2
- 210000001989 nasopharynx Anatomy 0.000 title abstract 2
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 208000005141 Otitis Diseases 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 208000019258 ear infection Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2722296P | 1996-10-01 | 1996-10-01 | |
| US2722496P | 1996-10-01 | 1996-10-01 | |
| US2722396P | 1996-10-01 | 1996-10-01 | |
| GBGB9716805.8A GB9716805D0 (en) | 1997-08-09 | 1997-08-09 | Novel composition and use |
| GBGB9719203.3A GB9719203D0 (en) | 1997-09-11 | 1997-09-11 | Novel composition and use |
| PCT/GB1997/002664 WO1998014189A1 (en) | 1996-10-01 | 1997-09-29 | Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991548D0 NO991548D0 (no) | 1999-03-30 |
| NO991548L true NO991548L (no) | 1999-03-31 |
Family
ID=27517419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991548A NO991548L (no) | 1996-10-01 | 1999-03-30 | Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6001870A (cs) |
| EP (1) | EP0939631A1 (cs) |
| JP (1) | JP2001504091A (cs) |
| KR (1) | KR20000048812A (cs) |
| CN (1) | CN1239427A (cs) |
| AR (1) | AR010995A1 (cs) |
| AU (1) | AU724070B2 (cs) |
| BR (1) | BR9711843A (cs) |
| CA (1) | CA2267248A1 (cs) |
| CZ (1) | CZ112499A3 (cs) |
| HU (1) | HUP9904308A3 (cs) |
| IL (1) | IL129237A0 (cs) |
| NO (1) | NO991548L (cs) |
| NZ (1) | NZ334913A (cs) |
| PL (1) | PL332642A1 (cs) |
| TR (1) | TR199900733T2 (cs) |
| WO (1) | WO1998014189A1 (cs) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4910145A1 (es) | 1996-10-01 | 2000-04-24 | Smithkline Beecham Corp | Uso |
| PL332642A1 (en) * | 1996-10-01 | 1999-09-27 | Smithkline Beecham Corp | Application of mupyrrocin in production of a drug for treating bacterial infections associated with invasion of nasopharynx by pathogenic organisms |
| CA2299298A1 (en) * | 1997-08-09 | 1999-02-18 | Jane Elizabeth Hilton | Compositions for nasal administration |
| UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
| GB9808470D0 (en) | 1998-04-22 | 1998-06-17 | Smithkline Beecham Plc | Novel process and apparatus |
| GB9902138D0 (en) | 1999-02-02 | 1999-03-24 | Smithkline Beecham | Container |
| JP2003515311A (ja) * | 1999-02-03 | 2003-05-07 | ビオガル ジョジセルジャール アール テー． | 微生物学的方法によるシュードモン酸ａ抗生物質の調製方法 |
| EP1185246A1 (de) * | 1999-06-02 | 2002-03-13 | Klöcker, Norbert, Dr.med. | Pharmazeutische zusammmensetzung zur nasalen anwendung von wasserunlöslichen und/oder schwer wasserlöslischen wirkstoffen |
| US6156294A (en) * | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US6676930B2 (en) * | 1999-11-28 | 2004-01-13 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US7439045B2 (en) * | 2001-06-21 | 2008-10-21 | TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság | pH controlled fermentation process for pseudomonic acid production |
| CA2460970C (en) | 2001-12-28 | 2005-10-18 | Biogal Gyogyszergyar Rt | Processes for preparing crystalline and amorphous mupirocin calcium |
| US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| ES2339682T3 (es) * | 2004-06-01 | 2010-05-24 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Procedimiento para la preparacion de la forma amorfa de un farmaco. |
| CN101137357B (zh) | 2005-03-10 | 2012-07-04 | 3M创新有限公司 | 含有羟基羧酸的酯的抗微生物组合物 |
| CN101175474B (zh) | 2005-03-10 | 2011-09-07 | 3M创新有限公司 | 降低微生物污染的方法 |
| CN101137359B (zh) * | 2005-03-10 | 2011-01-12 | 3M创新有限公司 | 治疗耳感染的方法 |
| GB2437488A (en) * | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
| US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
| US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
| US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
| US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
| US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
| CA2727432C (en) | 2008-06-12 | 2016-10-11 | Medtronic Xomed, Inc. | Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| US20100021563A1 (en) * | 2008-07-24 | 2010-01-28 | Paul Levesque | Compositions comprising coconut oil and methods of use thereof |
| WO2010042427A2 (en) | 2008-10-06 | 2010-04-15 | Microbial Defense Systems, Llc | Antimicrobial composition and methods of making and using same |
| EP3456200B1 (en) | 2011-05-10 | 2023-05-03 | Next Science IP Holdings Pty Ltd | Article having an antimicrobial solid and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ200918A (en) * | 1981-07-02 | 1985-07-31 | Gist Brocades Nv | Stable fatty oil-in-water emulsion cream for topical application |
| CA1196284A (en) * | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
| SE8206744D0 (sv) * | 1982-11-26 | 1982-11-26 | Fluidcarbon International Ab | Preparat for kontrollerad avgivning av substanser |
| GB8415579D0 (en) * | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
| GB8530796D0 (en) * | 1985-12-13 | 1986-01-22 | Beecham Group Plc | Pharmaceutical composition |
| IE59628B1 (en) * | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
| US5594026A (en) * | 1990-12-11 | 1997-01-14 | Smithkline Beecham Group P.L.C. | Polymorphs of crystalline mupirocin |
| PT727979E (pt) * | 1993-10-22 | 2001-11-30 | Smithkline Beckman Corp | Nova composicao |
| PL332642A1 (en) * | 1996-10-01 | 1999-09-27 | Smithkline Beecham Corp | Application of mupyrrocin in production of a drug for treating bacterial infections associated with invasion of nasopharynx by pathogenic organisms |
-
1997
- 1997-09-29 PL PL97332642A patent/PL332642A1/xx unknown
- 1997-09-29 KR KR1019990702807A patent/KR20000048812A/ko not_active Withdrawn
- 1997-09-29 TR TR1999/00733T patent/TR199900733T2/xx unknown
- 1997-09-29 JP JP51631398A patent/JP2001504091A/ja active Pending
- 1997-09-29 BR BR9711843-5A patent/BR9711843A/pt not_active IP Right Cessation
- 1997-09-29 CA CA002267248A patent/CA2267248A1/en not_active Abandoned
- 1997-09-29 IL IL12923797A patent/IL129237A0/xx unknown
- 1997-09-29 EP EP97943966A patent/EP0939631A1/en not_active Withdrawn
- 1997-09-29 NZ NZ334913A patent/NZ334913A/en unknown
- 1997-09-29 HU HU9904308A patent/HUP9904308A3/hu unknown
- 1997-09-29 WO PCT/GB1997/002664 patent/WO1998014189A1/en not_active Application Discontinuation
- 1997-09-29 AU AU45623/97A patent/AU724070B2/en not_active Ceased
- 1997-09-29 CZ CZ991124A patent/CZ112499A3/cs unknown
- 1997-09-29 CN CN97180242A patent/CN1239427A/zh active Pending
- 1997-09-30 AR ARP970104497A patent/AR010995A1/es unknown
- 1997-09-30 US US08/940,730 patent/US6001870A/en not_active Expired - Fee Related
-
1999
- 1999-03-30 NO NO991548A patent/NO991548L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9711843A (pt) | 2001-07-31 |
| CA2267248A1 (en) | 1998-04-09 |
| HUP9904308A3 (en) | 2002-06-28 |
| EP0939631A1 (en) | 1999-09-08 |
| KR20000048812A (ko) | 2000-07-25 |
| TR199900733T2 (xx) | 1999-07-21 |
| AR010995A1 (es) | 2000-08-02 |
| PL332642A1 (en) | 1999-09-27 |
| NO991548D0 (no) | 1999-03-30 |
| HUP9904308A2 (hu) | 2001-04-28 |
| AU724070B2 (en) | 2000-09-14 |
| NZ334913A (en) | 2001-03-30 |
| AU4562397A (en) | 1998-04-24 |
| WO1998014189A1 (en) | 1998-04-09 |
| US6001870A (en) | 1999-12-14 |
| CZ112499A3 (cs) | 1999-08-11 |
| IL129237A0 (en) | 2000-02-17 |
| CN1239427A (zh) | 1999-12-22 |
| JP2001504091A (ja) | 2001-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO991548L (no) | Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer | |
| AU1388892A (en) | Intermediates for the manufacture of 6-fluoro-1, 4-dihydro-4-oxoquinoline carboxylic acids | |
| GEP19991538B (en) | Derivatives of Erytromycin and Pharmaceutical Composition on their Basis | |
| AU3311095A (en) | Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use | |
| GR3015879T3 (en) | Novel hydroxamic acid and n-hydroxyurea derivatives and their use. | |
| ATE461928T1 (de) | Antibakterielle wirkstoffe | |
| ATE274916T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
| ES8800160A1 (es) | Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales. | |
| ATE246192T1 (de) | Ethyliden-derivate tricyclyscher carbapenems | |
| Ravishankar et al. | In vitro antibacterial efficacy of sutures coated with Aloe vera and ciprofloxacin: A comparative evaluation | |
| AU563831B2 (en) | N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives | |
| DE3887686D1 (de) | Bakterielle zubereitung für die prophylaxe und behandlung von entzuendungen und allergischen beschwerden. | |
| NZ510153A (en) | Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals | |
| EP1123692A3 (fr) | Utilisation de dérivés de polyaminoacides pour traiter la séborrhée et les désordres cutanés associés | |
| NO982863L (no) | Nye forbindelser med analgetisk effekt | |
| DE69739775D1 (de) | Verabreichung von Produkten des 5-lipoxygenase Synthesewegs zur Behandlung von mikrobiellen Infektionen | |
| FR2380277A1 (fr) | L'antibiotique desacetyl, dihydro 890 a9 | |
| DK1232173T3 (da) | Nye fusidinsyrederivater | |
| HK1022629A (en) | Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms | |
| TH34599B (th) | อนุพันธ์พลียูโรมิวทิลินที่เป็นสารต้านจุลินทรีย์ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |